In the rapidly advancing field of surgical technology, hospitals are facing the challenge of integrating robotic equipment into operating rooms that were not originally designed for such purposes. To address this issue, Johnson & Johnson MedTech has developed the groundbreaking OTTAVA robotic surgical system. Unlike its predecessors, this general surgery robot offers a unique design that seamlessly integrates into any operating room layout while maximizing valuable space.
One of the standout features of the OTTAVA system is its ability to adapt to various OR layouts and accommodate different clinical approaches. By incorporating four robotic arms into a standard size surgical table, OTTAVA simplifies complex workflows and provides flexibility for surgeons. These robotic arms can be effortlessly deployed or retracted under the surgical table as needed, offering an invisible design that optimizes the working area.
What sets the OTTAVA system apart is its “twin motion” capability, which synchronizes the movements of the operating table and the robotic arms. This innovation allows surgeons to reposition the patient mid-procedure without interrupting the surgical workflow. Additionally, the system utilizes Ethicon’s trusted surgical instruments, renowned for their precision and effectiveness, ensuring a seamless transition for surgeons between conventional laparoscopic and robotic-assisted surgeries.
Recognizing the potential of the OTTAVA system, Johnson & Johnson MedTech plans to submit an investigational device exemption (IDE) application to the U.S. Food & Drug Administration (FDA) in the second half of 2024. This application will kickstart clinical trials to assess the system’s performance and efficacy. Once approved, the OTTAVA robotic surgical system will join Johnson & Johnson’s existing line of robotic systems, which includes the MONARCH Platform and the VELYS Robotic-Assisted Solution.
The OTTAVA system is a testament to Johnson & Johnson MedTech’s commitment to improving surgical experiences and health outcomes. Hani Abouhalka, Company Group Chairman, Robotics & Digital, Johnson & Johnson MedTech, emphasized their dedication to personalizing the future of surgery. By enhancing the connection between patients, surgeons, and OR staff, the OTTAVA system exemplifies the marriage of science and technology in revolutionizing surgical care.
Q: What is the purpose of the OTTAVA robotic surgical system?
A: The purpose of the OTTAVA system is to simplify complex workflows, enhance OR flexibility, and create space in the operating room while integrating robotic technology.
Q: How does the OTTAVA system accommodate different operating room layouts?
A: By incorporating four robotic arms into a standard size surgical table, the OTTAVA system seamlessly integrates into any OR layout, offering an invisible design that optimizes the use of space.
Q: What is the “twin motion” capability of the OTTAVA system?
A: The “twin motion” capability synchronizes the movements of the operating table and the robotic arms, allowing surgeons to reposition the patient during surgery without interrupting the procedure.
Q: When will the OTTAVA robotic surgical system undergo clinical trials?
A: Johnson & Johnson MedTech plans to submit an investigational device exemption (IDE) application to the FDA in the second half of 2024 to initiate clinical trials for the OTTAVA system.
Sources: Johnson & Johnson MedTech